**Lead**
Philadelphia Eagles quarterback Jalen Hurts recently disclosed that he is taking blood thinners as part of his recovery protocol, a revelation that has drawn widespread attention to the often misunderstood world of anticoagulant therapy. While Hurts’s specific medical details remain private, his public acknowledgment has prompted a surge of online searches about blood thinners — and raised concerns among medical professionals that fans and patients alike may be underestimating the risks. As the National Football League star prepares for the upcoming season, healthcare specialists are using the moment to highlight five common and potentially dangerous mistakes patients make when taking anticoagulants.
**Context**
Blood thinners, or anticoagulants, are medications that reduce the blood’s ability to form clots. They are prescribed to millions of Americans for conditions such as atrial fibrillation, deep vein thrombosis, pulmonary embolism, and following certain surgeries or injuries. According to the Centers for Disease Control and Prevention, approximately 6 million people in the United States use anticoagulants regularly. While these drugs are highly effective at preventing strokes and life-threatening clots, they also carry a significant risk of bleeding, which can be severe or even fatal.
The conversation around anticoagulant safety is not new, but it gained fresh urgency when athletes like Hurts bring it into the public eye. In professional sports, where physical contact and injury are routine, the management of blood thinners requires extreme precision. A misstep — such as a missed dose or an interaction with another substance — can have catastrophic consequences on the field. The NFL and the NFL Players Association have protocols for players on anticoagulants, including mandatory monitoring and restrictions on certain types of training. But off the field, ordinary patients face many of the same risks, often without the same level of medical oversight.
**Analysis**
The first major mistake, experts say, is inconsistent dosing. Unlike many medications, blood thinners require strict adherence to a schedule. Skipping a dose, doubling up, or taking them at irregular times can lead to dangerous fluctuations in the blood’s clotting ability. A study published in the *Journal of the American Heart Association* found that nearly one in four patients on warfarin — a common anticoagulant — do not maintain a stable international normalized ratio, increasing their risk of both clotting and bleeding events.
The second mistake involves dietary interactions. Foods rich in vitamin K, such as kale, spinach, and broccoli, can interfere with warfarin. Patients are often told to eat a consistent amount of vitamin K rather than avoid it entirely, but many either over-restrict their diet or swing wildly between high and low intake. For newer anticoagulants like apixaban and rivaroxaban, food interactions are less of a concern, but the third mistake — combining blood thinners with other medications or supplements — remains a serious hazard. Over-the-counter pain relievers like ibuprofen and naproxen, as well as certain herbal supplements like ginkgo biloba and St. John’s wort, can dramatically increase bleeding risk.
The fourth mistake is failing to recognize warning signs of internal bleeding. Many patients assume that a small cut or bruise is normal. However, symptoms such as blood in the urine or stool, black tarry stools, severe headaches, unusual bruising, or coughing up blood require immediate medical attention. The fifth mistake, and perhaps the most underreported, is lack of communication with healthcare providers before undergoing elective procedures or even dental work. Dental cleanings, colonoscopies, and minor surgeries often require temporary discontinuation of blood thinners, but the timing and management of this process must be carefully coordinated by a physician.
**Impact and Broader Implications**
The visibility of an athlete like Jalen Hurts discussing his treatment can have a powerful effect on public health awareness. According to data from the National Institutes of Health, celebrity health disclosures often lead to spikes in patient inquiries and even changes in treatment adherence. However, they can also lead to misinformation if not accompanied by accurate medical guidance. The American Heart Association and the American College of Cardiology have both issued statements encouraging patients to use media moments as a catalyst for reviewing their own medication regimens with a healthcare professional.
For the millions of Americans on blood thinners — many of whom are older adults managing chronic conditions — the lesson is clear: these drugs are not to be taken casually. Technological advances, such as direct oral anticoagulants and home monitoring devices, have improved safety, but human error remains the leading cause of adverse events. Hospitals and health systems are increasingly using electronic health records and pharmacist-led interventions to reduce these mistakes, but patient education remains the most critical line of defense.
**Sources**
- Centers for Disease Control and Prevention (CDC) — Anticoagulant Use Statistics - *Journal of the American Heart Association* — Patient Adherence and INR Stability - National Institutes of Health (NIH) — Impact of Celebrity Health Disclosures - American Heart Association — Patient Guidance on Anticoagulants - American College of Cardiology — Clinical Recommendations for Anticoagulation Management
Por Renan Filho · 2026-10-24